I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Hypoxic ischemic encephalopathy (HIE) was reported as an important cause of neonatal morbidity and mortality worldwide.\[[@ref1][@ref2]\] About one-quarter of neonates who were diagnosed as HIE develop permanent neurological deficit including mental retardation, cerebral palsy, hearing or visual impairment, and epilepsy.\[[@ref3]\] Over a period of hours to days, hypoxic ischemic insult triggers a cascade of adverse events that lead to irreversible grey and/or white matter injury. It is not easy to suspect whether newborn will develop renal impairment. There is an urgent need for prediction of adverse renal outcomes in neonates with HIE.\[[@ref4]\]

*Aim of the work:* To evaluate renal function in the form of serum creatinine levels in full-term neonates with HIE and their correlation with severity degree of HIE, which is represented by Sarnat scoring and computerized axial tomography (CAT).

S[UBJECTS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
================================================

This prospective case--control study was conducted on 72 neonates who were classified into two groups: Group 1 included 36 full-term neonates (their gestational age ranged from 37 to 42 weeks) who were diagnosed as HIE and admitted to the neonatal intensive care unit of Tanta University Hospital, Egypt, from April 2017 till April 2018.

Neonates were diagnosed with HIE according to the World Health Organization definition of HIE if they had shown at least two of the following findings: Apgar score \<3 at 1min or \<6 at 5min, arterial pH \<7.2 with base deficit \>10 mmol/L, and the presence of postnatal clinical complications, which attributed to birth asphyxia, such as convulsion, abnormality in mental state, hypotension requiring positive inotropic support, severe apnea, and oliguria.

Neonatal acute kidney injury (AKI) was diagnosed according to the criteria of Kidney Disease Improving Global Outcome.\[[@ref5]\]

Group 2 included 36, apparently healthy neonates who were matched for age and sex and recruited as a control group.

Exclusion criteria:

\- Increased serum creatinine, which was attributed to causes other than HIE such as hypovolemia, sepsis, or infection.- Life-threatening congenital anomalies, inborn errors of metabolism, or preterm births.

This study was carried out after obtaining written consents from the parents of included subjects and after obtaining approval from research ethics committee of Tanta Faculty of Medicine in accordance with the Declaration of Helsinki.

All subjects were subjected to the following:

Full history taking: Focusing on gestational age, postnatal age, sex, neurological symptoms such as fits, perinatal history including mode of delivery, Apgar scoring at 1 and 5min, and neonatal resuscitation measures.Through clinical examination which included: - General examinations- Vital signs and urine output- Anthropometric measurements, especially body weight- Systemic examination- Neurological examination- Level of consciousness: whether alert, lethargic, or comatoseMotor system, including muscle power, muscle tone, and reflexesHIE Sarnat staging system: HIE was defined as mild, moderate, or severe using the Sarnat and Sarnat staging system.\[[@ref6]\] The assessed elements included level of consciousness, muscle tone, muscle tendon and tendon reflexes, seizures, autonomic function, and electroencephalogram description.Laboratory investigations, which were carried out for all subjects (patients and controls), included:- Complete blood count (CBC)- Liver function tests- Serum electrolytes, including serum sodium (Na), serum potassium (K), and serum calcium (Ca)- Arterial blood gases (ABG) to measure PH, PaO~2~, PaCO~2~, and base excess- Serum creatinine levels by routine laboratory techniqueImaging radiological investigations:- Brain CAT scan that was carried out for all cases.

Collection of blood samples: A total of 3mL of venous blood was taken from all studied groups. Blood samples were centrifuged at 4000rpm for 10min. Serum samples were separated and stored at refrigerator at --2 to --80°C until the time of laboratory assay.

S[TATISTICAL]{.smallcaps} A[NALYSIS]{.smallcaps} {#sec1-3}
================================================

All data were analyzed using the Statistical Package for the Social Sciences (SPSS) software, version 20.0, for analysis, (Methodology, Methods and technigues, 2^nd^ edition. New Delhi, India). According to the type of data, the following tests were performed to test differences for significance: differences between frequencies for qualitative variables and percentages in groups were compared by chi-square test and differences between mean values of quantitative variables of two parametric groups by t test. *P* value was set at \<0.05 for significant results and \<0.001 for highly significant result.\[[@ref7]\]

R[ESULTS]{.smallcaps} {#sec1-4}
=====================

[Table 1](#T1){ref-type="table"} shows demographic and clinical data of the studied patients and controls. No statistically significant difference was observed between the studied groups with regard to gestational age, weight, or sex (*P* \> 0.05).

###### 

Demographic and clinical characteristics of the studied cases and the controls

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameter                                                           Statistical parameter   Group 1 (patients)\   Group 2 (controls)\   Statistical test   *P* value
                                                                                              (*N* = 36)            (*N* = 36)                               
  ------------------------------------------ ------------------------ ----------------------- --------------------- --------------------- ------------------ -----------
  Gestational age (weeks)                    Mean ± SD                38.27 ± 0.95            38.05 ± 1.05          0.66                  0.5                

  Gender                                     Male:                    No. (%)                 26 (72.2)             22 (61.1)             0.5                0.48

  Female:                                    No. (%)                  10 (27.8)               14 (38.9)                                                      

  Mode of delivery                           NVD                      No. (%)                 28 (77.7%)            12 (33.3%)            1.77               0.18

  CS                                         No. (%)                  8 (22.2%)               24 (66.7%)                                                     

  Birth weight (kg)                                                   Mean ± SD               3.16 ± 0.47           3.15 ± 0.36           0.12               0.89

  Apgar score                                at 1 min                 Mean ± SD               2.5 ± 0.51            6.3 ± 0.84            16.5               0.001\*

  at 5 min                                   Mean ± SD                5 ± 0.87                8.7 ± 0.64            14.5                  0.001\*            

  Maternal risk factors                      Maternal preeclampsia    No. (%)                 10 (27.8%)            8 (22.2%)             1.59               0.02\*

  Maternal diabetes mellitus                 No. (%)                  8 (22.2%)               2 (5.6%)              2.09                  0.14               

  PROM                                       No. (%)                  8 (22.2%)               2 (5.6%)              1.12                  0.28               

  Antepartum hemorrhage                      No. (%)                  10 (27.8%)              2 (5.6%)              5.8                   0.016\*            

  Maternal risk factors                      Maternal renal failure   No. (%)                 8 (22.2%)             0 (0%)                2.11               0.14

  Sarnat and Sarnat Staging of HIE:          Stage 1                  No. (%)                 16 (44.4%)            \-                    \-                 \-

  Stage 2                                    No. (%)                  12 (33.3%)              \-                                                             

  Stage 3                                    No. (%)                  8 (22.2%)               \-                                                             

  Resuscitation steps                        Free oxygen flow         No. (%)                 0 (0%)                14 (38.9%)            8.69               0.003\*

  Assisted ventilation (Ambu bagging only)   No. (%)                  16 (44.4%)              22 (61.1%)            1                     0.31               

  ETT                                        No. (%)                  12 (33.3%)              0 (0%)                7.2                   0.007              

  Chest compression                          No. (%)                  6 (16.7%)               0 (0%)                3.27                  0.07               

  Medications                                No. (%)                  2 (5.6%)                0 (0%)                1.02                  0.31               

  Impaired conscious level                   Alert                    No. (%)                 22 (61.1%)            36 (100%)             0.3                0.1

  Lethargy                                   No. (%)                  8 (22.2%)               0 (0%)                5.09                  0.00               

  Coma                                       No. (%)                  6 (16.7%)               0 (0%)                2.4                   0.00               

  Muscle tone                                Normotonia               No. (%)                 20 (55.6%)            36 (100%)             1.68               0.9

  Hypotonia                                  No. (%)                  12 (33.3%)              0 (0%)                9.8                   0.00               

  Hypertonia                                 No. (%)                  6 (16.1%)               0 (0%)                9.12                  0.00               

  Tendon reflexes                            Normal                   No. (%)                 24 (66.7%)            36 (100%)             0.27               0.7

  Abnormal                                   No. (%)                  12 (33.3%)              0 (0%)                9.5                   0.00               

  Convulsions                                No convulsions           No. (%)                 18 (50%)              36 (100%)             0.94               0.56

  Tonic--clonic                              No. (%)                  12 (33.3%)              0 (0%)                17.9                  0.001\*            

  Subtle                                     No. (%)                  6 (16.7%)               0 (0%)                10.4                  0.001\*            
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

SD = standard deviation, PROM = premature rupture of membrane, NVD = normal vaginal delivery, CS = ciserean section \*P value \<0.05 significant

A statistically significant increase was observed in the patient group when compared to controls with regard to history of maternal hypertension associated with or complicating pregnancy or antepartum hemorrhage (*P* \< 0.05).

No statistically significant difference was observed between the studied groups with regard to mode of delivery (normal vaginal delivery vs. cesarean section) (*P* \> 0.05).

As per the Apgar score at 1 and 5min for cases and controls, a statistically significant decrease was observed in cases when compared to controls (*P* \< 0.05).

With regard to neonatal resuscitation measures for the studied groups, a statistically significant increase was reported in the use of free oxygen flow and insertion of endotracheal tube (ETT) in cases than that in controls (*P* \< 0.05).

[Table 2](#T2){ref-type="table"} shows the laboratory findings of the studied patients and controls including CBC, ABG, serum electrolytes, liver enzymes, blood urea, and serum creatinine levels.

###### 

Laboratory characteristics of the studied cases and the controls

  ---------------------------------------------------------------------------------------------------------------------------------------------
  Parameter                              Statistical parameter   Group 1\                Group 2\                Statistical test   *P* value
                                                                 (patients) (*N* = 36)   (controls) (*N* = 36)                      
  -------------------------- ----------- ----------------------- ----------------------- ----------------------- ------------------ -----------
                             WBCs        Mean ± SD               14.7 ± 9.9              3.4 ± 1.6               5.09               0.001

                             RBCs        Mean ± SD               4.1 ± 1.3               5.2 ± 1.9               2.49               0.015

  CBC                        HB          Mean ± SD               12.7 ± 1.1              16.4 ± 1.5              1.4                0.14

                             Platelets   Mean ± SD               193 ± 91.9              186.1 ± 60.5            0.3                0.76

  ABG                        pH          No. (%)                 7.03 ± 0.13             7.39 ± 0.03             11.2               0.000\*

  PCO~2~ (mm Hg)             No. (%)     30.5 ± 12.7             39.2 ± 3.06             2.2                     0.02               

  PO~2~ (mm Hg)              Mean ± SD   39.5 ± 16.6             37.1 ± 6.5              7.8                     0.001\*            

  HCO~3~ (mmol/L)            Mean ± SD   11.1 ± 2.9              22 ± 2.1                12.5                    0.001\*            

  BE (meq/L)                 Mean ± SD   -11.1 ± 3.5             0.55 ± 0.23             3.9                     0.35               

  Serum Ca                               Mean ± SD               0.99 ± 0.14             1.25 ± 0.07             11.28              0.001\*

  Serum Na                               Mean ± SD               129.6 ± 7.2             134.3 ± 6.3             2.4                0.016\*

  Serum K                                Mean ± SD               4.4 ± 0.75              4.5 ± 0.1               0.54               0.58

  SGPT                                   Mean ± SD               113.5 ± 114.2           21.1 ± 5.2              3.4                0.002\*

  SGOT                                   Mean ± SD               110.2 ± 104.09          20.9 ± 5.06             3.6                0.001\*

  Serum creatinine (mg/dL)               Mean ± SD               0.87 ± 0.76             0.36 ± 0.21             2.7                0.01\*

  Blood urea (mg/dL)                     Mean ± SD               64.05 ± 22.7            27.16 ± 5.5             3.1                0.004\*
  ---------------------------------------------------------------------------------------------------------------------------------------------

SD = standard deviation, RBCs = red blood cells, HB = hemoglobin, BE = base excess, SGPT = serum glutamate pyruvate transferase, SGOT = serum glutamate oxaloacetae transferase

\**P* value \<0.05 significant

Regarding clinical presentations of the studied neonates, they were classified according to Sarnat and Sarnat stages of HIE into stages I, II, and III.

[Table 3](#T3){ref-type="table"} shows the comparison of serum creatinine levels in studied patient subgroups according to Sarnat and Sarnat staging. This table showed that means of serum creatinine levels were significantly increased with the increase in severity of HIE according to Sarnat and Sarnat staging.

###### 

Comparison of serum creatinine level in studied patient subgroups according to Sarnat staging

  Parameter                  Sarnat I (*N* = 16)   Sarnat II (*N* = 12)   Sarnat III (*N* = 8)   *P* value
  -------------------------- --------------------- ---------------------- ---------------------- -----------
  Serum creatinine (mg/dL)   0.51 ± 0.19           0.74 ± 0.25            1.3 ± 0.5              0.001

[Table 4](#T4){ref-type="table"} shows the relation between serum creatinine levels and radiological findings of CAT of brain among the studied cases, a statistically significant difference was observed among serum creatinine levels regarding findings of CAT of brain with marked elevation in serum creatinine levels, which correlate with the severity of HIE shown by radiological findings of CAT of brain.

###### 

Comparison between serum creatinine in the studied patients according to findings of CAT brain

  CAT brain         Serum creatinine At day 7 (mg/dL)   *t*    *P* value
  ----------------- ----------------------------------- ------ -----------
  Normal            0.44 ± 0.15                         5.01   0.02
  Brain edema       0.51 ± 0.01                                
  Severe ischemia   0.73 ± 0.011                               

SD = standard deviation

D[ISCUSSION]{.smallcaps} {#sec1-5}
========================

Perinatal asphyxia is an insult to the fetus and/or neonates because of lack of oxygen (hypoxia) and/or lack of perfusion (ischemia) to various organs. It is associated with tissue lactic acidosis and hypercapnia. The sequelae of hypoxia and ischemia may not be identical, but they are difficult to be separated clinically. Both factors probably contribute to multisystem injury.\[[@ref8]\]

Hypoxic--ischemic injury is the most important consequence of perinatal asphyxia.\[[@ref8]\]

Reperfusion of previously ischemic tissue may also enhance the formation of excess oxygen free radicals (known as reactive oxygen species), which may cause damage of cellular lipids, proteins, nucleic acid, and the blood--brain barrier.\[[@ref9]\]

In response to acute hypoxia, the fetal and neonatal cardiovascular system attempts to preserve blood flow to the brain, heart, kidney, and adrenals. Multiple organ injury including AKI occurs in 70% of infants with the diagnosis of HIE, as evidence of end-organ involvements is necessary to meet the definition of birth asphyxia.\[[@ref10]\]

Previously, it was unknown that the extent of systemic organ involvement might or might not correlate with the severity of encephalopathy. This can be transient and reversible. In fact, the central nervous system is often the main organ system that has residual sequelae at long-term follow-up.\[[@ref11]\]

Many physiopathological mechanisms that were involved in the brain damage were related to HIE of the neonates. Early assessment of the severity of an acute cerebral lesion secondary to hypoxia--ischemia may provide a very useful basis for preventive or therapeutic modalities.

In our study, regarding brain CAT scanning, 24 (66.7%) showed no abnormal radiological findings, 4 (11.1%) had brain edema, and 8 (22.2%) had severe ischemic findings.

Our study agreed with the results of the study by Volpe,\[[@ref12]\] which reported that infants with normal CAT scans rarely exhibit major neurological deficits on follow-up and infants with scans showing marked diffuse hypodensity are rarely normal on follow-up.

Our study disagreed with the findings of the study by Tippin *et al*.\[[@ref13]\] Although CAT scan may occasionally show early changes, it is most often normal hours after the insult and may remain unremarkable at later stages, even in patients with extensive neurological damage.\[[@ref14]\]

In our study, a significant increase was observed regarding blood urea and serum creatinine levels in cases group when compared to that in control group (*P* \< 0.05). These results were in agreement with Huang *et al*.\[[@ref15]\] who found that serum urea and creatinine level were significantly elevated in their patient group with HIE in comparison to their control group. Bhantnagar *et al*.\[[@ref16]\] also reported that the concentration of blood urea and serum creatinine was significantly higher in their patients who were hypoxic ischemic when compared to that in their control group. These findings were in accordance also with those of Gupta *et al*.,\[[@ref17]\] who found that serum creatinine and blood urea levels were significantly higher in asphyxiated newborns compared to those in control group.

Our results were in accordance with many previously published articles including those of Gopal,\[[@ref18]\] Alaro *et al*.,\[[@ref19]\] and Amardiyanto *et al*.\[[@ref20]\]

In this study, results of serum creatinine and blood urea levels were significantly correlated with the degree of HIE according to Sarnat and Sarnat staging as the level of serum creatinine in patient subgroups differs according to the Sarnat score. Sarnat stage I patients had a mean level of 0.51±0. 19mg/dL. The mean level of serum creatinine for Sarnat II patients was 0.74±0.25mg/dL, whereas Sarnat III subgroup had a mean serum creatinine level of 1.3±0.5mg/dL.

These findings mean that blood urea and serum creatinine levels showed a highly significant increase with increased severity of Sarnat stages. These results were in accordance with the findings of Gupta *et al*.,\[[@ref17]\] who studied renal failure in asphyxiated neonates and stated that blood urea and serum creatinine levels were significantly higher in asphyxiated neonates when compared to that in the control group. A rising trend in the concentrations of blood urea and serum creatinine was also observed as HIE staging progressed, and the difference was statistically significant.

Andreoli,\[[@ref21]\] Gharehbaghi and Peirovifar,\[[@ref22]\] and El-Gamasy and Nassar\[[@ref23]\] reported that HIE was one of the most prevalent risk factors for AKI in newly born infants.

In our study, a statistically significant increase was observed in serum creatinine levels in cases with abnormal CAT radiological findings of the brain when compared with those without brain radiological abnormalities by CAT scan and a significantly increase was observed in serum creatinine levels in cases with severe ischemia when compared with those with brain edema as CAT findings of the brain.

Our results were in accordance with the study by Park *et al*.,\[[@ref24]\] who studied correlations between the severity of HIE and the development of acute renal failure (ARF) in asphyxiated neonates and found that the greater the degree of HIE, the higher incidence of ARF.

C[ONCLUSION]{.smallcaps} {#sec1-6}
========================

Serum creatinine levels correlate with the severity of HIE as serum creatinine levels significantly increased with the increase in the severity of HIE according to Sarnat and Sarnat staging.

A statistically significant difference was observed among serum creatinine levels regarding CAT radiological findings of brain. This means that a marked elevation in serum creatinine levels correlate with the severity of HIE by CAT findings of brain. So higher serum creatinine levels than normal for age were an indicator for the severity of HIE.
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